118 related articles for article (PubMed ID: 6308685)
1. Urinary excretion of prostacyclin and thromboxane A2 metabolites after angiotensin converting enzyme inhibition in hypertensive patients.
Vlasses PH; Ferguson RK; Smith JB; Rotmensch HH; Swanson BN
Prostaglandins Leukot Med; 1983 Jun; 11(2):143-50. PubMed ID: 6308685
[TBL] [Abstract][Full Text] [Related]
2. Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects.
Chiabrando C; Rivoltella L; Martelli L; Valzacchi S; Fanelli R
Biochim Biophys Acta; 1992 Feb; 1133(3):247-54. PubMed ID: 1737057
[TBL] [Abstract][Full Text] [Related]
3. Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins.
Ylikorkala O; Kuusi T; Tikkanen MJ; Viinikka L
J Clin Endocrinol Metab; 1987 Dec; 65(6):1238-42. PubMed ID: 2960690
[TBL] [Abstract][Full Text] [Related]
4. Thromboxane antagonism and cough induced by angiotensin-converting-enzyme inhibitor.
Malini PL; Strocchi E; Zanardi M; Milani M; Ambrosioni E
Lancet; 1997 Jul; 350(9070):15-8. PubMed ID: 9217714
[TBL] [Abstract][Full Text] [Related]
5. Urinary excretion of degradation products of prostacyclin and thromboxane is increased in patients with gestational choriocarcinoma.
Aitokallio-Tallberg AM; Jung JK; Kim SJ; Viinikka LU; Ylikorkala RO
Cancer Res; 1991 Aug; 51(16):4146-8. PubMed ID: 1868436
[TBL] [Abstract][Full Text] [Related]
6. The effect of a thromboxane synthetase inhibitor, OKY-046, on urinary excretion of immunoreactive thromboxane B2 and 6-keto-prostaglandin F1 alpha in patients with ischemic cerebrovascular disease.
Uyama O; Nagatsuka K; Nakabayashi S; Isaka Y; Yoneda S; Kimura K; Abe H
Stroke; 1985; 16(2):241-4. PubMed ID: 3883580
[TBL] [Abstract][Full Text] [Related]
7. Urinary excretion of TXB2 after angiotensin converting enzyme inhibition in hypertensive patients.
Kudo K; Abe K; Chiba S; Omata K; Sato K; Yasugima M; Sato M; Yoshinaga K
Prostaglandins Leukot Med; 1986 Jan; 21(1):77-86. PubMed ID: 3006084
[TBL] [Abstract][Full Text] [Related]
8. Prostacyclin: its pathogenic role in essential hypertension and the class effect of ACE inhibitors on prostaglandin metabolism.
Rodríguez-García JL; Villa E; Serrano M; Gallardo J; García-Robles R
Blood Press; 1999; 8(5-6):279-84. PubMed ID: 10803488
[TBL] [Abstract][Full Text] [Related]
9. Differing effects of two angiotensin converting enzyme inhibitors, captopril and CI-906, on diuresis and the urinary excretion of kallikrein and prostaglandins in spontaneously hypertensive rats.
Säynävälammi P; Pörsti I; Nurmi AK; Seppälä E; Laitinen LA; Manninen V; Ylitalo P; Vapaatalo H
Scand J Urol Nephrol Suppl; 1984; 79():23-7. PubMed ID: 6089314
[TBL] [Abstract][Full Text] [Related]
10. Thromboxane and prostacyclin formation in patients with deep vein thrombosis.
Vesterqvist O; Gréen K; Johnsson H
Thromb Res; 1987 Feb; 45(4):393-402. PubMed ID: 3554598
[TBL] [Abstract][Full Text] [Related]
11. Absence of effects of ketanserin on renal prostacyclin and thromboxane A2 in essential hypertension.
Gambini G; Rossi S; Valori C
Eur Heart J; 1991 Apr; 12(4):550-3. PubMed ID: 2065689
[TBL] [Abstract][Full Text] [Related]
12. Altered excretion of prostaglandin and thromboxane metabolites in pregnancy-induced hypertension.
Minuz P; Covi G; Paluani F; Degan M; Lechi C; Corsato M; Lechi A
Hypertension; 1988 Jun; 11(6 Pt 1):550-6. PubMed ID: 3290103
[TBL] [Abstract][Full Text] [Related]
13. Volume-induced natriuresis in healthy women: renal metabolism of prostacyclin and thromboxane, and physiological role of prostanoids.
Agnoli GC; Borgatti R; Cacciari M; Lenzi P; Marinelli M; Stipo L
Prostaglandins Leukot Essent Fatty Acids; 2001 Feb; 64(2):95-103. PubMed ID: 11237476
[TBL] [Abstract][Full Text] [Related]
14. Effect of the infusion of OKY-046, a thromboxane A2 synthase inhibitor, on urinary metabolites of prostacyclin and thromboxane A2 in healthy human subjects.
Morio H; Hirai A; Terano T; Tamura Y; Yoshida S
Thromb Haemost; 1993 Mar; 69(3):276-81. PubMed ID: 8470052
[TBL] [Abstract][Full Text] [Related]
15. An increase in the ratio of thromboxane A2 to prostacyclin in association with increased blood pressure in patients on cyclosporine A.
Förstermann U; Kühn K; Vesterqvist O; Gréen K; Frei U; Brunkhorst R; Haas J; Koch KM; Frölich JC
Prostaglandins; 1989 May; 37(5):567-75. PubMed ID: 2662262
[TBL] [Abstract][Full Text] [Related]
16. Prostacyclin versus thromboxane metabolite excretion: changes in pregnancy and labor.
Noort WA; Keirse MJ
Eur J Obstet Gynecol Reprod Biol; 1990 Apr; 35(1):15-21. PubMed ID: 2107105
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of angiotensin converting enzyme inhibitors on the vasodepressor and prostacyclin responses to bradykinin.
Brown NJ; Ryder D; Gainer JV; Morrow JD; Nadeau J
J Pharmacol Exp Ther; 1996 Nov; 279(2):703-12. PubMed ID: 8930174
[TBL] [Abstract][Full Text] [Related]
18. Decreased systemic formation of prostaglandin E and prostacyclin, and unchanged thromboxane formation, in alcoholics during withdrawal as estimated from metabolites in urine.
Förstermann U; Feuerstein TJ
Clin Sci (Lond); 1987 Sep; 73(3):277-83. PubMed ID: 3308287
[TBL] [Abstract][Full Text] [Related]
19. [The influence of sodium ferulate on hypotensive effect and urinary excretion of TXB2 after captopril in essential hypertensive patients].
Xu XY; Wang Q
Zhong Xi Yi Jie He Za Zhi; 1991 Nov; 11(11):657-8, 644. PubMed ID: 1667512
[TBL] [Abstract][Full Text] [Related]
20. Excretion of metabolites of prostacyclin and thromboxane by rats with nephrotoxic nephritis: effects of interleukin-1.
Ward PS; Fuller RW; Ritter JM; Cashman SJ; Rees AJ; Dollery CT
Br J Pharmacol; 1991 Jul; 103(3):1663-8. PubMed ID: 1933130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
